Search Results
No results were found...
DARE Application Information Session 2023
The DARE Application Information Session 2023 will took place on Saturday 14 January. You can view this session below which includes a general presentation on
HEAR Application Information Session 2023
This session includes a general presentation on HEAR and how to apply to it, as well as a Questions and Answers session on how to make a successful application. It will also provide an opportunity for you and/or your parent(s)/ guardian(s) to meet members of the HEAR team online and find out how the scheme works.
Changes to DARE 2023: Specific Learning Difficulties (SpLD)
DARE has changed its eligibility criteria for Specific Learning Difficulties (SpLD) for entry-2023 onwards to make the scheme even more inclusive. These changes are based
Review & Appeals
DARE Reviews and Appeals Click on whichever one applies to you: I missed the DARE deadline The CAO has an Independent Appeals Commission to which
My Uni Life Documentary Series
View the series
My Uni Life Documentary Series
View the series
Guide to posting your documents
Guide to posting your documents Keep photocopies of ALL documents that you are posting. Put your name and CAO number on every document you send.
Carrying Forward Eligibility
Carrying forward eligibility from 2022 to 2023 Please only complete this section if you applied to AND were eligible for DARE last year. Eligibility for
Search
Search Results No results were found…
Speech and Language Communication Disorder
(Including (but not exclusively) Stammering; Receptive and/or Expressive Language Disorders; Unintelligibility due to a phonological disorder, articulation disorder associated with structural anomalies; Acquired communication disorders
Significant Ongoing Illness
(Including (but not exclusively) Diabetes Type 1, Cystic Fibrosis (CF), Severe Crohn’s Disease, Severe Ulcerative Colitis and Irritable Bowel Disease (IBD), Chronic Fatigue, Cancers(including those
Physical Disability
This category of DARE is reserved for those with significant mobility difficulties. For example applications for those with Hypermobility or Costochondritis may be considered for